POLY MEDICURE
Back to Cashflow Statement
|
POLY MEDICURE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹20 Cr | ₹951 Cr | ₹-20 Cr | ₹-13 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of POLY MEDICURE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹20 Cr |
| Mar2025 | ₹951 Cr |
| Mar2024 | ₹-20 Cr |
| Mar2023 | ₹-13 Cr |
| Mar2022 | ₹-35 Cr |
How is Cash Flow from Financing Activities of POLY MEDICURE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹20 Cr | -97.88 | |
| Mar2025 | ₹951 Cr | Positive | |
| Mar2024 | ₹-20 Cr | Negative | |
| Mar2023 | ₹-13 Cr | Negative | |
| Mar2022 | ₹-35 Cr | - | |
Compare Cash Flow from Financing Activities of peers of POLY MEDICURE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| POLY MEDICURE | ₹14,833.8 Cr | 1.4% | -10.6% | -23% | Stock Analytics | |
| LENSKART SOLUTIONS | ₹118,621.0 Cr | 9% | 4% | NA | Stock Analytics | |
| 3B BLACKBIO DX | ₹1,166.8 Cr | 2% | -14% | -2% | Stock Analytics | |
| LAXMI DENTAL | ₹980.4 Cr | 4.6% | -7.7% | -42.6% | Stock Analytics | |
| PREVEST DENPRO | ₹456.3 Cr | 0.7% | -0.7% | -25.7% | Stock Analytics | |
| NURECA | ₹290.1 Cr | -5.2% | -15.2% | -5% | Stock Analytics | |
POLY MEDICURE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| POLY MEDICURE | 1.4% |
-10.6% |
-23% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses